This HTML5 document contains 62 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q63597162
rdf:type
wikibase:Item
schema:description
klinisch onderzoek clinical trial клінічне випробування ensayu clínicu
rdfs:label
To Evaluate the Safety and Tolerability of Treatment With Atogepant 60 mg Daily for the Prevention of Migraine in Participants With Episodic Migraine
skos:prefLabel
To Evaluate the Safety and Tolerability of Treatment With Atogepant 60 mg Daily for the Prevention of Migraine in Participants With Episodic Migraine
schema:name
To Evaluate the Safety and Tolerability of Treatment With Atogepant 60 mg Daily for the Prevention of Migraine in Participants With Episodic Migraine
p:P1476
wds:Q63597162-1BEB9F95-2098-4763-8FE5-EE34CEC3AFCD
wdt:P1476
A Phase 3, Multicenter, Randomized, Open-label Study to Evaluate the Long-term Safety and Tolerability of Oral Atogepant for the Prevention of Migraine in Participants With Episodic Migraine.
p:P582
wds:Q63597162-D2887190-640F-4442-A4E4-FE6ACA2B2175
wdt:P582
2020-06-22T00:00:00Z
p:P31
wds:Q63597162-527C5C72-279B-4FC0-8298-2A12941B1B9B
wdt:P31
wd:Q30612
p:P580
wds:Q63597162-B83BDB7E-BEE7-4029-9171-0347E9073779
wdt:P580
2018-10-08T00:00:00Z
p:P17
wds:Q63597162-B199EC75-8433-4360-8385-DC6E28D79567
wdt:P17
wd:Q30
p:P6153
wds:Q63597162-165B9AB9-9A15-4B52-8299-CE9E9886CB8D wds:Q63597162-854CF86C-46A5-485B-8A90-74BD7B928E38 wds:Q63597162-7C6677DC-6519-4FFD-A1AA-3507B8F23E7D wds:Q63597162-96A09558-2DC3-4F59-A25A-5532654AE391 wds:Q63597162-87A713B0-9821-42C6-BE6F-585F457B16D9 wds:Q63597162-63A66CDA-6DFC-4F84-9EFB-BCE586A3337E wds:Q63597162-66A13521-7073-40C1-B31A-F55F42072433 wds:Q63597162-C12E650B-506D-4EED-A75B-1DC5DEDA8BFA wds:Q63597162-C7221820-CDAE-4BC0-AEE8-6549C6891277 wds:Q63597162-A334D32A-F7A9-4B89-A645-271A83D4C196 wds:Q63597162-9EC73316-12EB-441B-B863-9B44D2B3610A wds:Q63597162-ED2BCAF1-36BD-44C9-B6A1-ADCA21BECC05 wds:Q63597162-36AE9D6F-1E56-41D2-89B4-C97C34DD4AE0 wds:Q63597162-433FFCC9-9C07-4A36-A4DC-4F661FF4ECC0 wds:Q63597162-41E02DA2-B675-4F15-8A4E-1315EDDF4887 wds:Q63597162-12CAA9B7-132B-4980-9DC0-3D5C46B24327
wdt:P6153
wd:Q30269657 wd:Q50035554 wd:Q30270436 wd:Q50036830 wd:Q30270268 wd:Q30270193 wd:Q30269643 wd:Q30269696 wd:Q30282378 wd:Q30282105 wd:Q30298472 wd:Q30269646 wd:Q30269704 wd:Q30281497 wd:Q30269571 wd:Q30269430
p:P2899
wds:Q63597162-1793B8F2-0413-4D5C-898F-4D2DED388AA6
wdt:P2899
18
p:P1132
wds:Q63597162-DAA1D908-6C2A-4FDA-9933-7BFC0B48B398
wdt:P1132
700
p:P4135
wds:Q63597162-745F766A-1CDF-421C-90E6-98A60EE50A09
wdt:P4135
80
p:P8363
wds:Q63597162-B4EC225C-E549-425C-983E-03737765D358
wdt:P8363
wd:Q78089383
p:P3098
wds:Q63597162-10A7B784-45CE-4FA7-A042-4FA8129A337E
wdt:P3098
NCT03700320
p:P6099
wds:Q63597162-05AF0B41-F0A2-4255-8AD4-317EFDB2AA3F
wdt:P6099
wd:Q42824827